Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
11/06/1990 | US4968670 Pyridine-2,4- and 2,5-dicarboxylic acid derivatives, a process for their preparation, the use thereof, and medicaments based on these compounds |
11/06/1990 | US4968607 Interleukin-1 receptors |
11/06/1990 | CA1276025C Aminoalkylpyridineamides |
11/06/1990 | CA1275951C Lysing or blocking unwanted cells |
11/04/1990 | CA2015888A1 Monoclonal antibodies specific for an immunoglobulin isotype |
11/03/1990 | WO1990014068A2 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof |
11/03/1990 | CA2032138A1 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof |
11/02/1990 | WO1990013548A1 Heterocyclic n-oxide derivatives of substituted benzo[5,6]cycloheptapyridines, compositions and methods of use |
11/01/1990 | WO1990012806A1 Synthetic peptides of the conjugate of ubiquitine and histone h2a |
11/01/1990 | WO1990010705A3 Production and purification of recombinant human interleukin-3 and muteins thereof |
10/31/1990 | EP0395120A2 Method of passive immunization of mammals using bovid antibody and compositions for same |
10/31/1990 | EP0394542A1 Bone marrow cell recovery with synthetic csf inducers |
10/31/1990 | EP0394302A1 DNA ENCODING IgE RECEPTOR $g(a)-SUBUNIT OR FRAGMENT THEREOF |
10/30/1990 | US4966973 Lipoxygenase inhibitors |
10/29/1990 | CA2015735A1 Glycoprotein from avena sativa, process for its preparation, and pharmaceutical compositions containing same |
10/28/1990 | CA2015294A1 Generation and expansion of lak cells |
10/24/1990 | EP0393786A1 New retro-inverse, one- or more bond bearing analogues of thymopentin, a method for synthesizing the same and their employment for the preparation of pharmaceutical |
10/24/1990 | EP0393738A1 Hydroxyalkylfuranyl derivatives |
10/24/1990 | EP0393604A2 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS |
10/24/1990 | EP0393502A1 Soluble interferon-gamma receptors and methods for their production |
10/24/1990 | EP0383764A4 Bovine granulocyte-macrophage colony stimulating factor |
10/23/1990 | US4965347 Beta-D-glucan, and its production and uses |
10/23/1990 | US4965284 Immunomodulators |
10/23/1990 | US4965276 Administering 4-trifluoromethylanilide of 5-methylisoxazole-4-carboxylic acid and/or n-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide |
10/23/1990 | US4965274 Quinolyl methoxy compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
10/23/1990 | US4965271 Administering 7-(oxoalkyl)-1,3-dialkyl xanthines |
10/23/1990 | US4965266 Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same |
10/23/1990 | US4965258 Anticoagulant; thromboxane a2 antagonist |
10/23/1990 | US4965250 Peptide compounds having a nitrogenous polycyclic structure |
10/22/1990 | WO1990012592A1 Recombinant antibody-toxin fusion protein |
10/21/1990 | CA2015053A1 Retro-inverse, one- or more-bond bearing analogues of thymopentin, a method for synthesizing the same and their employment for the preparation of pharmaceutical |
10/21/1990 | CA2014841A1 Macrolides having immunosuppressive activity |
10/20/1990 | CA2014926A1 Oral preparation |
10/19/1990 | WO1990012812A1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
10/19/1990 | CA2031507A1 Proteins which regulate the expression of vertebrate mhc class ii genes, dna sequences encoding them and pharmaceutical compositions |
10/19/1990 | CA2014752A1 Soluble interferon-gamma receptors and methods for their production |
10/18/1990 | WO1990012344A1 Fast printer with a particle trap in the paper channel |
10/18/1990 | WO1990011761A1 Treatment of aids dementia, myelopathy and blindness |
10/17/1990 | EP0392315A1 Pure Histone H1 for use in therapeutic procedures |
10/17/1990 | EP0392122A1 Lymphokines |
10/17/1990 | EP0392095A2 Tuftsin analogues and vaccines containing these as adjuvants |
10/17/1990 | EP0392038A1 Acylureidoaminothiazolyl derivatives and process for their preparation |
10/17/1990 | EP0391962A1 Compositions possessing immunostimulating properties and their applications in human and veterinary medecine |
10/17/1990 | CN1046161A Hydroxyalkylfuranyl derivatives |
10/16/1990 | US4963653 Sialic acid-bonded octapeptide and preparation thereof |
10/16/1990 | US4963588 Use of ubenimex for treating myelodysplastic syndrome |
10/16/1990 | US4963578 Organic compounds and their pharmaceutical use |
10/16/1990 | US4963576 Antiallergens, antiinflammatory agents; 5-lipoxygenase inhibitor |
10/16/1990 | US4963564 Phenethanolamine derivatives |
10/16/1990 | US4963560 1,4-dihydropyridine derivatives |
10/16/1990 | US4963557 Immunomodulatory azaspiranes |
10/16/1990 | CA1275251C Medicaments to combat chronic graft-versus-host diseases and to combat autoimmune diseases, in particular systemic lupus erythematosus |
10/11/1990 | WO1990012585A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
10/11/1990 | CA2028825A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
10/10/1990 | EP0391002A2 Pharmaceutical compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid |
10/09/1990 | US4962207 Organic derivatives of tellurium and selenium |
10/09/1990 | US4962035 DNA encoding IgE receptor alpha-subunit or fragment thereof |
10/09/1990 | US4961927 Clear solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate |
10/09/1990 | CA1275044A1 Method of passive immunization of mammals using avian and/or bovid antibody and compositions for same |
10/07/1990 | WO1990011760A1 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
10/07/1990 | CA2030530A1 Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
10/07/1990 | CA2013892A1 Hydroxyalkylfuranyl derivatives |
10/04/1990 | WO1990011294A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
10/04/1990 | WO1990011293A1 Allergenic proteins from ragweed and uses therefor |
10/04/1990 | WO1990011287A1 Matrix metalloproteinase inhibitor peptides |
10/04/1990 | WO1990011271A1 New leukotriene b4 derivatives, process for producing them and their use as drugs |
10/04/1990 | WO1990011092A1 Expression of exogenous polynucleotide sequences in a vertebrate |
10/04/1990 | WO1990011085A1 Large multivalent immunogen |
10/04/1990 | DE4010316A1 Thieno-triazolo-diazepinderivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische zusammensetzungen Thieno-triazolo-diazepine derivatives, to processes for their preparation and therapeutic compositions containing |
10/04/1990 | CA2489769A1 Expression of exogenous polynucleotide sequences in a vertebrate |
10/04/1990 | CA2357538A1 Expression of exogenous polynucleotide sequences in a vertebrate |
10/04/1990 | CA2046909A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
10/03/1990 | EP0390718A1 Process for preparing new 1-diphenylmethylpiperidine derivatives |
10/03/1990 | EP0390683A1 Benzyl-cyclanones derivatives, process for their preparation and cosmetic and pharmaceutical compositions containing them |
10/03/1990 | EP0390682A1 Cosmetic and pharmaceutical compositions containing hydrophilic derivatives of benzylidene camphor and sulfonated hydrophilic derivatives of benzylidene camphor |
10/03/1990 | EP0390681A1 Cosmetic and pharmaceutical compositions containing lipophile derivatives of benzylidene-camphor and lipophile benzylidene-camphor derivatives |
10/03/1990 | EP0390252A2 Purification of recombinant human interleukin-3 |
10/03/1990 | EP0390039A2 N-Acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use in the manufacture of immunomodulators and immunoadjuvants |
10/03/1990 | EP0389590A1 Milk constituents, process for producing them and agents containing them |
10/03/1990 | CN1045783A Diazepine antiallergy agents |
10/03/1990 | CN1045778A Substituted (quinolin-2-yl-methoxy) phenyl-n,n'-sulphonylureas, processes for their preparation and their use in medicaments |
10/03/1990 | CN1045777A Process for preparation of alpha-substd. 4-(quinolin-2-yl-methoxy) phenylacetic acids and esters |
10/02/1990 | WO1990012015A1 Dihydropyridine antiallergy agents |
10/02/1990 | US4960908 Antibody inhibitor and anticarcinogenic agent |
10/02/1990 | US4960892 Naphthalenepropionic acid derivatives as anti-inflammatory/anti-allergic agents |
10/02/1990 | US4960776 Antiallergens |
10/02/1990 | US4960700 Compositions and methods for the synthesis and assay of a mammalian enkephalinase |
10/02/1990 | CA2048684A1 Antiallergy agents |
10/01/1990 | WO1990012106A1 Production of beta-1,3-glucan in algae |
10/01/1990 | WO1990012008A1 Urea based lipoxygenase inhibiting compounds |
10/01/1990 | CA2050597A1 Urea based lipoxygenase inhibiting compounds |
10/01/1990 | CA2028838A1 Production of beta-1, 3-glucan in algae |
09/30/1990 | CA2013557A1 Cosmetic and pharmaceutical compositions containing lipophilic benzylidene camphor derivatives and new lipophilic benzylidene camphor derivatives |
09/30/1990 | CA2013556A1 Cosmetic and pharmaceutical compositions containing hydrophilic benzylidene camphor derivatives and new hydrophilic sulfonated derivatives of benzylidene camphor |
09/28/1990 | CA2013187A1 Process for preparing new 1-diphenylmethylpiperidine derivatives |
09/27/1990 | CA2013065A1 N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use in the manufacture of immunomodulators and immunoadjuvants |
09/26/1990 | EP0389282A2 Xanthinederivatives, process for their preparation and their pharmaceutical use |
09/26/1990 | EP0389189A2 Diazepine antiallergy agents |
09/26/1990 | EP0389035A1 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
09/26/1990 | EP0388909A2 Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same |